WSJ Health Blog's March Madness drug company CEO brackets

Posted By

Tags

At a conference yesterday, Scott Hensley of the Wall Street Journal Health blog showed off a story I had missed. Since it’s the last day of March and basketball’s Final Four is now set, the time is just right to look at it. See the Journal’s “Our March Madness: The Drug Company CEO Bracketâ€?.

They explain:

Restless shareholders, listless labs and a tidal wave of generic competition confront the top executives at drug makers around the globe. Big Biotech has plenty of problems of its own. Did we mention pushback on prices?

So we wonder who among the leaders of the current executive pack will win the test of endurance to remain the last CEO standing? Take a look at our second annual bracket by clicking on the image at the right. Feel free to start your own office pool.

The posting is fun. It’s interactive. You can vote on the poll. And the user comments are worth reading. One wrote: “A more relevant question is – which CEO has the most integrity?”

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.